Methods and compositions for treating cancer
AssigneeCity of Hope
InventorsJianjun Chen, Rui Su, David Horne, Xiaolan Deng, Hongzhi Li, Jun Xie
Life of this patent
Estimating the term…
Abstract
Provided, inter alia, are methods and compositions for treating FTO-mediated cancer.
Claims64
A method of treating cancer in a subject in need thereof, the method comprising administering a therapeutically effective amount of an FTO inhibitor, wherein the subject has an elevated level of FTO when compared to a control, and wherein the FTO inhibitor has the structural formula I or II,
- or an enantiomer or mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.
(canceled)
(canceled)
(canceled)
(canceled)
A compound of formula Ia, Ib, (IIa) or an enantiomer or mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof:
- wherein
- R1 and R2 are independently hydrogen, halogen, —CCl3, —CBr3, —CF3, —CI3, —CH2Cl, —CH2Br, —CH2F, —CH2I, —CHCl2, —CHBr2, —CHF2, —CHI2, —CN, —OH, —NH2, —COOH, —CONH2, —NO2, —SH, —SO3H, —SO4H, —SO2NH2, —NHNH2, —ONH2, —NHC(O)NHNH2, —NHC(O)NH2, —NHSO2H, —NHC(O)H, —NHC(O)OH, —NHOH, —OCCl3, —OCBr3, —OCF3, —OCI3, —OCH2Cl, —OCH2Br, —OCH2F, —OCH2I, —OCHCl2, —OCHBr2, —OCHF2, —OCHI2, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, wherein at least one of R1 or R2 is not hydrogen.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of measuring FTO levels in a subject, the method comprising:
- (i) obtaining a biological sample from the subject;
- and (ii) measuring FTO levels in the biological sample;
- wherein if the FTO level is elevated when compared to a control, the subject is identified as responsive to the FTO inhibitor and wherein if the FTO level is elevated when compared to a control, the subject is selected for treatment with the FTO inhibitor.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of measuring FTO levels in a subject wherein the subject has cancer, the method comprising:
- (i) obtaining a biological sample from the subject;
- and (ii) measuring FTO levels in the biological sample.
(canceled)
(canceled)
(canceled)
(canceled)
A method of treating cancer in a subject in need thereof, the method comprising:
- (i) obtaining a biological sample from the subject;
- and (ii) measuring FTO levels in the biological sample;
- and (iii) administering a therapeutically effective amount of an FTO inhibitor.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of preparing a sample from a subject having cancer, the method comprising:
- (i) extracting a protein fraction or an RNA fraction from a sample from said subject;
- and
- (ii) detecting a level of FTO protein in said protein fraction or a level of FTO encoding RNA in said RNA fraction.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.